Bevacizumab and type 1 idiopathic macular telangiectasia
Main Authors: | Koay, C.L., Chew, F.L.M., Visvaraja, S. |
---|---|
Format: | Article |
Published: |
2011
|
Subjects: |
Similar Items
-
Intravitreal Bevacizumab Treatment in Type 2 Idiopathic Macular Telangiectasia
by: Tuğba Aydoğan, et al.
Published: (2016-12-01) -
Topical piperacillin/tazobactam for recalcitrant pseudomonas aeruginosa keratitiS
by: Chew, F.L.M., et al.
Published: (2010) -
Management of Idiopathic Macular Telangiectasia Type 2
by: Alireza Khodabande, et al.
Published: (2019-02-01) -
Type 1 Idiopathic Macular Telangiectasia Associated with Type 3 Neovascularization
by: Julien Tilleul, et al.
Published: (2014-11-01) -
Combined photodynamic therapy and intravitreal bevacizumab as primary treatment for subretinal neovascularization associated with type 2 idiopathic macular telangiectasia
by: Rishi Pukhraj, et al.
Published: (2009-01-01)